GELESIS HLDGS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GELESIS HLDGS and buy or sell other stocks, ETFs, and their options commission-free!

About GLSHQ

Gelesis Holdings, Inc. operates as a biotechnology company. The firm engages in developing a novel category of therapies for weight management and gut related chronic diseases. 

CEO
Yishai Zohar
CEOYishai Zohar
Employees
100
Employees100
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2006
Founded2006
Employees
100
Employees100

GLSHQ Key Statistics

Market cap
7.33K
Market cap7.33K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
400.00
Average volume400.00
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.0001
52 Week high$0.0001
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

As of today, GELESIS HLDGS(GLSHQ) shares are valued at $0.00. The company's market cap stands at 7.33K.

On 2026-07-17, GELESIS HLDGS(GLSHQ) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for GELESIS HLDGS(GLSHQ) stock has reached 0, versus its average volume of 400.

Over the past 52 weeks, GELESIS HLDGS(GLSHQ) stock has traded between a high of $0.00 and a low of $0.00.

Over the past 52 weeks, GELESIS HLDGS(GLSHQ) stock has traded between a high of $0.00 and a low of $0.00.

People also own

Based on the portfolios of people who own GLSHQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.